# Systemic immune inflammation index guides machine learning for rapid TTP diagnosis: a retrospective cohort study

**Authors:** Zhenqi Liu, Xu Ye

PMC · DOI: 10.3389/fmed.2025.1599999 · Frontiers in Medicine · 2025-10-16

## TL;DR

This study uses machine learning and inflammatory markers to quickly diagnose TTP, a rare blood disorder, using routine blood tests.

## Contribution

A machine learning model using SII and other blood markers is proposed for rapid TTP diagnosis without specialized testing.

## Key findings

- Logistic regression achieved an AUC of 0.78 in distinguishing TTP from ITP.
- SII was identified as the most influential predictor in the model.
- The model offers a fast, accessible alternative for early TTP risk stratification.

## Abstract

Thrombotic thrombocytopenic purpura (TTP) is a rare, life threatening thrombotic microangiopathy that requires prompt diagnosis to reduce mortality. However, its early identification is often hindered by delayed ADAMTS13 testing, particularly in low resource settings. In this study, we developed a machine learning–based model using readily available inflammatory markers, including systemic immune inflammation index (SII), platelet to lymphocyte ratio (PLR), and platelet neutrophil product (PPN), to distinguish TTP from immune thrombocytopenia (ITP). A retrospective analysis of 196 hospitalized patients was conducted, and eight machine learning models were trained and compared. Logistic regression achieved the best performance (AUC = 0.78), with SII identified as the most influential predictor. While the PLASMIC score remains a widely used tool with higher diagnostic accuracy (AUC = 0.92), our model relies only on routine blood tests and offers a fast, accessible alternative for early risk stratification. These findings suggest that composite inflammatory markers combined with machine learning can assist in the rapid triage of suspected TTP cases, especially in emergency or resource-limited environments.

## Linked entities

- **Proteins:** ADAMTS13 (ADAM metallopeptidase with thrombospondin type 1 motif 13)
- **Diseases:** thrombotic thrombocytopenic purpura (MONDO:0018896), immune thrombocytopenia (MONDO:0002048)

## Full-text entities

- **Genes:** ADAMTS13 (ADAM metallopeptidase with thrombospondin type 1 motif 13) [NCBI Gene 11093] {aka ADAM-TS13, ADAMTS-13, C9orf8, VWFCP, vWF-CP}
- **Diseases:** TTP (MESH:D011697), thrombotic microangiopathy (MESH:D057049), ITP (MESH:D016553), immune inflammation (MESH:D007249)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12571784/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12571784/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12571784/full.md

---
Source: https://tomesphere.com/paper/PMC12571784